Abstract
Leishmaniasis, a parasitic disease found in parts of the tropics and subtropics, is caused by Leishmania protozoa infection. Nitroreductases (NTRs), enzymes involved in nitroaromatic prodrug activation, are attractive targets for leishmaniasis treatment development. In this study, a full-length recombinant NTR from the Leishmania orientalis isolate PCM2 (LoNTR), which causes severe leishmaniasis in Thailand, was successfully expressed in soluble form using chaperone co-expression in Escherichia coli BL21(DE3). The purified histidine-tagged enzyme (His6-LoNTR) had a subunit molecular mass of 36 kDa with no cofactor bound; however, the addition of exogenous flavin (either FMN or FAD) readily increased its enzyme activity. Bioinformatics analysis found that the unique N-terminal sequences of LoNTR is only present in Leishmania where the addition of this region might result in the loss of flavin binding. Either NADH or NADPH can serve as an electron donor to transfer electrons to nitrofurazone; however, NADPH was preferred. Molecular oxygen was identified as an additional electron acceptor resulting in wasteful electrons from NADPH for the main catalysis. Steady-state kinetic experiments revealed a ping-pong mechanism for His6-LoNTR with Km,NADPH, Km,NFZ, and kcat of 28 µM, 68 µM, and 0.84 min−1, respectively. Besides nitroreductase activity, His6-LoNTR also has the ability to reduce quinone derivatives. The properties of full-length His6-LoNTR were different from previously reported protozoa and bacterial NTRs in many respects. This study provides information of NTR catalysis to be developed as a potential future therapeutic target to treat leishmaniasis.
Similar content being viewed by others
Data Availability
All data are included in the article and supplementary material.
References
Cotton, J. A. (2017). The expanding world of human leishmaniasis. Trends in Parasitology, 33(5), 341–344. https://doi.org/10.1016/j.pt.2017.02.002
Leelayoova, S., Siripattanapipong, S., Manomat, J., Piyaraj, P., Tan-Ariya, P., Bualert, L., & Mungthin, M. (2017). Leishmaniasis in Thailand: A review of causative agents and situations. American Journal of Tropical Medicine and Hygiene, 96(3), 534–542. https://doi.org/10.4269/ajtmh.16-0604
Alvar, J., Velez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., den Boer, M., Team WHOLC. (2012). Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7(5), e35671. https://doi.org/10.1371/journal.pone.0035671
Leelayoova, S., Siripattanapipong, S., Hitakarun, A., Kato, H., Tan-ariya, P., Siriyasatien, P., Osatakul, S., & Mungthin, M. (2013). Multilocus characterization and phylogenetic analysis of Leishmania siamensis isolated from autochthonous visceral leishmaniasis cases, southern Thailand. BMC Microbiology, 13, 60. https://doi.org/10.1186/1471-2180-13-60
Sukmee, T., Siripattanapipong, S., Mungthin, M., Worapong, J., Rangsin, R., Samung, Y., Kongkaew, W., Bumrungsana, K., Chanachai, K., Apiwathanasorn, C., Rujirojindakul, P., Wattanasri, S., Ungchusak, K., & Leelayoova, S. (2008). A suspected new species of Leishmania, the causative agent of visceral leishmaniasis in a Thai patient. International Journal for Parasitology, 38(6), 617–622. https://doi.org/10.1016/j.ijpara.2007.12.003
Anuntasomboon, P., Siripattanapipong, S., Unajak, S., Choowongkomon, K., Burchmore, R., Leelayoova, S., Mungthin, M., & E-kobon, T. (2022). Comparative draft genomes of Leishmania orientalis isolate PCM2 (formerly named Leishmania siamensis) and Leishmania martiniquensis isolate PCM3 from the Southern province of Thailand. Biology (Basel), 11(4), 515. https://doi.org/10.3390/biology11040515
Raether, W., & Hanel, H. (2003). Nitroheterocyclic drugs with broad spectrum activity. Parasitology Research, 90, S19-39. https://doi.org/10.1007/s00436-002-0754-9
Wilkinson, S. R., Bot, C., Kelly, J. M., & Hall, B. S. (2011). Trypanocidal activity of nitroaromatic prodrugs: Current treatments and future perspectives. Current Topics in Medicinal Chemistry, 11(16), 2072–2084. https://doi.org/10.2174/156802611796575894
Patterson, S., & Wyllie, S. (2014). Nitro drugs for the treatment of trypanosomatid diseases: Past, present, and future prospects. Trends in Parasitology, 30(6), 289–298. https://doi.org/10.1016/j.pt.2014.04.003
Boddu, R. S., Perumal, O., & Divakar, K. (2021). Microbial nitroreductases: A versatile tool for biomedical and environmental applications. Biotechnology and Applied Biochemistry, 68(6), 1518–1530. https://doi.org/10.1002/bab.2073
Zhang, R., Shang, L., Jin, H., Ma, C., Wu, Y., Liu, Q., Xia, Z., Wei, F., Zhu, X. Q., & Gao, H. (2010). In vitro and in vivo antileishmanial efficacy of nitazoxanide against Leishmania donovani. Parasitology Research, 107(2), 475–479.
Wyllie, S., Patterson, S., & Fairlamb, A. H. (2013). Assessing the essentiality of Leishmania donovani nitroreductase and its role in nitro drug activation. Antimicrobial Agents and Chemotherapy, 57(2), 901–906. https://doi.org/10.1007/s00436-010-1906-y
Wyllie, S., Roberts, A. J., Norval, S., Patterson, S., Foth, B. J., Berriman, M., Read, K. D., & Fairlamb, A. H. (2016). Activation of bicyclic nitro-drugs by a novel nitroreductase (ntr2) in Leishmania. PLoS Pathogens, 12(11), e1005971. https://doi.org/10.1371/journal.ppat.1005971
Voak, A. A., Gobalakrishnapillai, V., Seifert, K., Balczo, E., Hu, L., Hall, B. S., & Wilkinson, S. R. (2013). An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs. Journal of Biological Chemistry, 288(40), 28466–28476. https://doi.org/10.1074/jbc.M113.494781
Mesquita, J. T., Pinto, E. G., Taniwaki, N. N., Galisteo, A. J., Jr., & Tempone, A. G. (2013). Lethal action of the nitrothiazolyl-salicylamide derivative nitazoxanide via induction of oxidative stress in Leishmania (L.) infantum. Acta Tropica, 128(3), 666–673. https://doi.org/10.1016/j.actatropica.2013.09.018
Petri e Silva, S. C., Palace-Berl, F., Tavares, L. C., Soares, S. R., & Lindoso, J. A. (2016). Effects of nitro-heterocyclic derivatives against Leishmania (L) infantum promastigotes and intracellular amastigotes. Experimental Parasitology, 163, 68–75. https://doi.org/10.1016/j.exppara.2016.01.007
Pinto, E. G., Barbosa, L. R. S., Mortara, R. A., & Tempone, A. G. (2020). Targeting intracellular Leishmania (L) infantum with nitazoxanide entrapped into phosphatidylserine-nanoliposomes: An experimental study. Chemico-Biological Interactions, 332, 109296. https://doi.org/10.1016/j.cbi.2020.109296
Lopes, M. S., de Souza Pietra, R. C., Borgati, T. F., Romeiro, C. F., Junior, P. A., Romanha, A. J., Alves, R. J., Souza-Fagundes, E. M., Fernandes, A. P., & de Oliveira, R. B. (2011). Synthesis and evaluation of the anti parasitic activity of aromatic nitro compounds. European Journal of Medicinal Chemistry, 46(11), 5443–5447. https://doi.org/10.1016/j.ejmech.2011.09.002
Mendonca, D. B. D., Silva, R. E. C., Palace-Berl, F., Takakura, C. F., Soares, S. R. C., Braz, L. M. A., Tavares, L. C., & Lindoso, J. A. L. (2019). Nitro-Heterocyclic compounds induce apoptosis-like effects in Leishmania (L.) amazonensis promastigotes. Journal of Venomous Animals and Toxins including Tropical Diseases, 25, e144418. https://doi.org/10.1590/1678-9199-JVATITD-1444-18
Chan-Bacab, M. J., Hernandez-Nunez, E., & Navarrete-Vazquez, G. (2009). Nitazoxanide, tizoxanide and a new analogue [4-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide; NTB] inhibit the growth of kinetoplastid parasites (Trypanosoma cruzi and Leishmania mexicana) in vitro. Journal of Antimicrobial Chemotherapy, 63(6), 1292–1293. https://doi.org/10.1093/jac/dkp117
de Oliveira, I. M., Henriques, J. A., & Bonatto, D. (2007). In silico identification of a new group of specific bacterial and fungal nitroreductases-like proteins. Biochemical and Biophysical Research Communications, 355(4), 919–925. https://doi.org/10.1016/j.bbrc.2007.02.049
Wilkinson, S. R., Taylor, M. C., Horn, D., Kelly, J. M., & Cheeseman, I. (2008). A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proceedings of the National Academy of Sciences USA, 105(13), 5022–5027. https://doi.org/10.1073/pnas.0711014105
Muller, J., Wastling, J., Sanderson, S., Muller, N., & Hemphill, A. (2007). A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrobial Agents and Chemotherapy, 51(6), 1979–1986. https://doi.org/10.1128/AAC.01548-06
Hall, B. S., Bot, C., & Wilkinson, S. R. (2011). Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites. Journal of Biological Chemistry, 286(15), 13088–13095.
Muller, J., Rout, S., Leitsch, D., Vaithilingam, J., Hehl, A., & Muller, N. (2015). Comparative characterisation of two nitroreductases from Giardia lamblia as potential activators of nitro compounds. International Journal for Parasitology: Drugs and Drug Resistance, 5(2), 37–43. https://doi.org/10.1016/j.ijpddr.2015.03.001
Moreno, S. N., Mason, R. P., & Docampo, R. (1984). Reduction of nifurtimox and nitrofurantoin to free radical metabolites by rat liver mitochondria: Evidence of an outer membrane-located nitroreductase. Journal of Biological Chemistry, 259(10), 6298–6305. https://doi.org/10.1016/S0021-9258(20)82140-1
Nishihara, K., Kanemori, M., Kitagawa, M., Yanagi, H., & Yura, T. (1998). Chaperone coexpression plasmids: Differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2 in Escherichia coli. Applied and Environmental Microbiology, 64(5), 1694–1699. https://doi.org/10.1128/AEM.64.5.1694-1699.1998
Studier, F. W. (2005). Protein production by auto-induction in high density shaking cultures. Protein Expression and Purification, 41(1), 207–234. https://doi.org/10.1016/j.pep.2005.01.016
Gerlt, J. A., Bouvier, J. T., Davidson, D. B., Imker, H. J., Sadkhin, B., Slater, D. R., & Whalen, K. L. (1854). (2015) Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST): A web tool for generating protein sequence similarity networks. Biochimica et Biophysica Acta, 8, 1019–1037. https://doi.org/10.1016/j.bbapap.2015.04.015
Shannon, P. T., Grimes, M., Kutlu, B., Bot, J. J., & Galas, D. J. (2013). RCytoscape: Tools for exploratory network analysis. BMC Bioinformatics, 14, 217–225. https://doi.org/10.1186/1471-2105-14-217
Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., Basutkar, P., Tivey, A. R. N., Potter, S. C., Finn, R. D., & Lopez, R. (2019). The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Research, 47(W1), W636–W641. https://doi.org/10.1093/nar/gkz268
Huerta-Cepas, J., Serra, F., & Bork, P. (2016). ETE 3: Reconstruction, analysis, and visualization of phylogenomic data. Molecular Biology and Evolution, 33(6), 1635–1638. https://doi.org/10.1093/molbev/msw046
Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/10.1093/nar/gky427
Hecht, H. J., Erdmann, H., Park, H. J., Sprinzl, M., & Schmid, R. D. (1995). Crystal structure of NADH oxidase from Thermus thermophilus. Natural Structural Biology, 2(12), 1109–1114. https://doi.org/10.1038/nsb1295-1109
Hall, B. S., & Wilkinson, S. R. (2012). Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation. Antimicrobial Agents and Chemotherapy, 56(1), 115–123. https://doi.org/10.1128/AAC.05135-11
Hall, B. S., Meredith, E. L., & Wilkinson, S. R. (2012). Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs. Antimicrobial Agents and Chemotherapy, 56(11), 5821–5830. https://doi.org/10.1128/AAC.01227-12
Haynes, C. A., Koder, R. L., Miller, A. F., & Rodgers, D. W. (2002). Structures of nitroreductase in three states: Effects of inhibitor binding and reduction. Journal of Biological Chemistry, 277(13), 11513–11520. https://doi.org/10.1074/jbc.M111334200
Kobori, T., Sasaki, H., Lee, W. C., Zenno, S., Saigo, K., Murphy, M. E., & Tanokura, M. (2001). Structure and site-directed mutagenesis of a flavoprotein from Escherichia coli that reduces nitrocompounds: Alteration of pyridine nucleotide binding by a single amino acid substitution. Journal of Biological Chemistry, 276(4), 2816–2823. https://doi.org/10.1074/jbc.M002617200
Piano, V., Palfey, B. A., & Mattevi, A. (2017). Flavins as covalent catalysts: New mechanisms emerge. Trends in Biochemical Sciences, 42(6), 457–469. https://doi.org/10.1016/j.tibs.2017.02.005
Pimviriyakul, P., & Chaiyen, P. (2020). Overview of flavin-dependent enzymes. In P. Chaiyen & F. Tamanoi (Eds.), The Enzymes (Vol. 47, pp. 1–36). Elsevier. https://doi.org/10.1016/bs.enz.2020.06.006
Watanabe, M., Nishino, T., Takio, K., Sofuni, T., & Nohmi, T. (1998). Purification and characterization of wild-type and mutant “classical” nitroreductases of Salmonella typhimurium mutation greatly diminishes binding of FMN to the nitroreductase of S. typhimurium. Journal of Biological Chemistry, 273(37), 23922–23928. https://doi.org/10.1074/jbc.273.37.23922
Valiauga, B., Williams, E. M., Ackerley, D. F., & Cenas, N. (2017). Reduction of quinones and nitroaromatic compounds by Escherichia coli nitroreductase A (NfsA): Characterization of kinetics and substrate specificity. Archives of Biochemistry and Biophysics, 614, 14–22. https://doi.org/10.1016/j.abb.2016.12.005
Zenno, S., Koike, H., Kumar, A. N., Jayaraman, R., Tanokura, M., & Saigo, K. (1996). Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. Journal of Bacteriology, 178(15), 4508–4514. https://doi.org/10.1128/jb.178.15.4508-4514.1996
Koder, R. L., & Miller, A. F. (1998). Steady-state kinetic mechanism, stereospecificity, substrate and inhibitor specificity of Enterobacter cloacae nitroreductase. Biochimica et Biophysica Acta, 1387(1–2), 395–405. https://doi.org/10.1016/s0167-4838(98)00151-4
Pitsawong, W., Hoben, J. P., & Miller, A. F. (2014). Understanding the broad substrate repertoire of nitroreductase based on its kinetic mechanism. Journal of Biological Chemistry, 289(22), 15203–15214. https://doi.org/10.1074/jbc.M113.547117
Perez-Reinado, E., Roldan, M. D., Castillo, F., & Moreno-Vivian, C. (2008). The NprA nitroreductase required for 2,4-dinitrophenol reduction in Rhodobacter capsulatus is a dihydropteridine reductase. Environmental Microbiology, 10(11), 3174–3183. https://doi.org/10.1111/j.1462-2920.2008.01585.x
Yanto, Y., Hall, M., & Bommarius, A. S. (2010). Nitroreductase from Salmonella typhimurium: Characterization and catalytic activity. Organic & Biomolecular Chemistry, 8(8), 1826–1832. https://doi.org/10.1039/b926274a
Yang, Y., Lin, J., & Wei, D. (2016). Heterologous overexpression and biochemical characterization of a nitroreductase from Gluconobacter oxydans 621H. Molecular Biotechnology, 58(6), 428–440. https://doi.org/10.1007/s12033-016-9942-1
Yang, J., Bai, J., Qu, M., Xie, B., & Yang, Q. (2019). Biochemical characteristics of a nitroreductase with diverse substrate specificity from Streptomyces mirabilis DUT001. Biotechnology and Applied Biochemistry, 66(1), 33–42. https://doi.org/10.1002/bab.1692
Acknowledgements
This work was supported by the grant from Kasetsart University Research and Development Institute; KURDI (FF (KU)4.65) (to P. Pimviriyakul), the grant from the Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation through grant RGNS 64-030 (to P. Pimviriyakul), the grant from Faculty of Science, Kasetsart University (to P. Pimviriyakul and Y. Kapaothong), and the grant from Development and Promotion of Science and Technology Talents Project (DPST) Scholarship (to T. Tangsupatawat). We thank Assist. Prof. Dr.Teerasak E-Kobon’s laboratory for the gene information.
Author information
Authors and Affiliations
Contributions
PP: Project administration, Supervision, Conceptualization, Methodology, Investigation, Data analysis, Writing—Original Draft, Review & Editing, Funding acquisition. YK and TT: Methodology, Data curation, Data analysis.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pimviriyakul, P., Kapaothong, Y. & Tangsupatawat, T. Heterologous Expression and Characterization of a Full-length Protozoan Nitroreductase from Leishmania orientalis isolate PCM2. Mol Biotechnol 65, 556–569 (2023). https://doi.org/10.1007/s12033-022-00556-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12033-022-00556-3